IP Library › Granted Patent US 12,237,078
Granted Patent B2
US 12,237,078 · App. 18/733,064 · Granted Feb 25, 2025

Plasma collection

Inventors: Brian C. Case (Lake Villa, IL); Lan T. Nguyen (Vernon Hills, IL); Amit J. Patel (Algonquin, IL); Samantha M. Planas (Wauconda, IL); Walter T. Watts (Lake Forest, IL); Kyungyoon Min (Kildeer, IL); Daniel R. Boggs (Libertyville, IL)
Assignee: FENWAL, INC.
G16H40/60A61B34/10A61M1/34A61M1/3403G06F21/31G08B3/10G08B5/22G16H10/60A61M2205/33A61M2205/3334
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,237,078
App. No.
18/733,064
Granted
Feb 25, 2025
Kind
B2
Abstract

A system and method for collecting plasma includes drawing whole blood from a donor, combining anticoagulant with the whole blood from the donor, separating the whole blood into a plasma product and a second blood component and sending the plasma product to a collection container. A controller determines a total blood volume for a donor based on donor weight, height and gender. The system comprises a touchscreen for receiving a confirming user input and a scanning device configured to scan a bar code associated with a donor. The system and method operate a plurality of draw and return phases.

Claims (47)

1. A method of collecting plasma, comprising:

introducing whole blood from a donor to a separator;

combining anticoagulant with the whole blood from the donor;

separating whole blood from the donor into a plasma product and a second blood component comprising red blood cells;

sending the plasma product to a plasma product collection container;

receiving input from an operator;

scanning a bar code associated with the donor; and

determining with a controller a total blood volume for the donor based at least in part on donor weight and donor height;

displaying on a touch screen a parameter which identifies the donor;

receiving a confirming user input via the touchscreen, and,

in response to the confirming user input, operating a plurality of draw and return phases to withdraw whole blood from a donor and separate the whole blood into the plasma product and the second blood component and to return the second blood component to the donor.

2. The method of claim 1 , wherein total blood volume is further determined by the controller based on donor gender.

3. The method of claim 1 , wherein the parameter which identifies the donor comprises the donor's name.

4. The method of claim 1 , further comprising determining a target volume for plasma product and/or raw plasma collection based at least in part on the total blood volume for the donor.

5. The method of claim 4 , further comprising, after controlling the system to operate one of the plurality of draw phases, establishing an updated value of hematocrit of the donor and a new target volume for plasma product and/or raw plasma based on the updated value of hematocrit, and controlling the system to operate a subsequent draw and return cycle, whereby the donor's changing hematocrit is taken into account in calculating the new target volume for plasma product and/or raw plasma.

6. The method of claim 1 , further comprising determining the target volume based further on a hematocrit of the donor.

7. The method of claim 1 , further comprising determining the donor's total blood volume before whole blood is withdrawn from the donor during a donation.

8. The method of claim 1 , wherein the method is configured to operate at least three draw and return phases during a donation.

9. A method of collecting plasma, comprising:

receiving input from an operator at a touch screen;

scanning a bar code associated with a donor to receive personal information about the donor;

displaying on the touch screen a parameter which identifies the donor;

receiving a confirming user input via the touchscreen;

determining a body mass for the donor based at least in part on donor weight and donor height using a controller; and

controlling a blood separator to operate a plurality of draw and return phases to withdraw whole blood from a donor, combine anticoagulant with the whole blood, and separate the whole blood into a plasma product and a second blood component and to return the second blood component to the donor, the blood separator having a plasma output port coupled to a plasma line configured to send the plasma product to a plasma product collection container.

10. The method of claim 9 , wherein the body mass is further determined based on donor gender.

11. The method of claim 9 , wherein the parameter which identifies the donor comprises the donor's first name, last name, and date of birth.

12. The method of claim 9 , further comprising determining, using the controller, a target volume for plasma product and/or raw plasma collection based at least in part on the body mass for the donor.

13. The method of claim 9 , further comprising, after controlling the system to operate one of the plurality of draw phases, establishing using the controller an updated value of hematocrit of the donor and a new target volume for plasma product and/or raw plasma based on the updated value of hematocrit; and controlling the system to operate a subsequent draw and return cycle, whereby the donor's changing hematocrit is taken into account in calculating the new target volume for plasma product and/or raw plasma.

14. The method of claim 9 , wherein the controller determines the target volume based further on a hematocrit of the donor.

15. The method of claim 9 , wherein the controller is configured to determine the donor's total blood volume before whole blood is withdrawn from the donor during a donation.

16. The method of claim 9 , wherein the controller is configured to operate at least three draw and return phases during a donation.

17. A method of collecting plasma, comprising:

separating whole blood into a plasma product and a second blood component comprising red blood cells;

sending the plasma product to a plasma product collection container;

introducing the whole blood from a donor to a separator;

combining anticoagulant with the whole blood from the donor;

receiving input from an operator;

scanning a bar code associated with the donor;

determining a target volume for plasma product and/or raw plasma collection based at least in part on donor weight and donor height;

displaying on a touch screen data which identifies the donor;

receiving a confirming user input via the touchscreen; and

operating a plurality of draw and return phases to withdraw whole blood from a donor and separate the whole blood into the plasma product and the second blood component and to return the second blood component to the donor.

18. The method of claim 17 , wherein the target volume for plasma product and/or raw plasma collection is based further on donor gender.

19. The method of claim 17 , wherein the data which identifies the donor comprises the first and last name and date of birth.

20. The method of claim 17 , further comprising determining the target volume based further on a hematocrit of the donor and before whole blood is withdrawn from the donor during a donation.

21. The method of claim 17 , wherein the operating step comprises operating at least three draw and return phases during a donation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2024
From: CASE, BRIAN C.; NGUYEN, LAN T.; PATEL, AMIT J.; PLANAS, SAMANTHA M.; WATTS, WALTER T.; MIN, KYUNGYOON; BOGGS, DANIEL R.
To: FENWAL, INC.
Reel/Frame 067614/0040 →
Continuity (8)
Continuation 18231638 · Aug 8, 2023
Continuation 17727476 · Apr 22, 2022
Continuation 17078824 · Oct 23, 2020
Continuation In Part PCTUS2019033318 · May 21, 2019
Provisional Application 62846400 · May 10, 2019
Provisional Application 62752480 · Oct 30, 2018
Provisional Application 62674144 · May 21, 2018
Related Publication 20240404692A1 · Dec 5, 2024
References Cited (400)
US 1025059A · Joseph et al. · 1912 [cited by applicant]
US 1611725A · Degerth et al. · 1926 [cited by applicant]
US 2087778A · Nelin · 1937 [cited by applicant]
US 2661150A · Abbott, Jr. · 1953 [cited by applicant]
US 2750107A · More · 1956 [cited by applicant]
US 2792172A · Tait · 1957 [cited by applicant]
US 3096283A · Hein · 1963 [cited by applicant]
US 3145713A · Latham · 1964 [cited by applicant]
US 3239136A · Hein · 1966 [cited by applicant]
US 3244362A · Hein · 1966 [cited by applicant]
US 3244363A · Hein · 1966 [cited by applicant]
US 3409213A · Latham · 1968 [cited by applicant]
US 3456875A · Hein · 1969 [cited by applicant]
US 3489145A · Judson et al. · 1970 [cited by applicant]
US 3565330A · Allen · 1971 [cited by applicant]
US 3655058A · Novak · 1972 [cited by applicant]
US 3737096A · Jones et al. · 1973 [cited by applicant]
US 3774840A · Boatright · 1973 [cited by applicant]
US 3987961A · Sinn et al. · 1976 [cited by applicant]
US 4007871A · Jones et al. · 1977 [cited by applicant]
US 4010894A · Kellogg et al. · 1977 [cited by applicant]
US 4014497A · Spiewok et al. · 1977 [cited by applicant]
US 4040965A · Kohlheb · 1977 [cited by applicant]
US 4056224A · Lolachi · 1977 [cited by applicant]
US 4082217A · Westberg · 1978 [cited by applicant]
US 4086925A · Dodge · 1978 [cited by applicant]
US 4140268A · Lacour · 1979 [cited by applicant]
US 4142670A · Ishimaru et al. · 1979 [cited by applicant]
US 4151844A · Almond et al. · 1979 [cited by applicant]
US 4197847A · Djerassi · 1980 [cited by applicant]
US 4285464A · Latham · 1981 [cited by applicant]
US 4300717A · Latham · 1981 [cited by applicant]
US 4303193A · Latham · 1981 [cited by applicant]
US 4321921A · Laszczower · 1982 [cited by applicant]
US 4387848A · Kellogg et al. · 1983 [cited by applicant]
US 4425114A · Schoendorfer et al. · 1984 [cited by applicant]
US 4430072A · Kellogg et al. · 1984 [cited by applicant]
US 4447221A · Mulzet · 1984 [cited by applicant]
US 4457747A · Tu · 1984 [cited by applicant]
US 4464167A · Schoendorfer et al. · 1984 [cited by applicant]
US 4466888A · Verkaart · 1984 [cited by applicant]
US 4482342A · Lueptow et al. · 1984 [cited by applicant]
US 4490135A · Troutner · 1984 [cited by applicant]
US 4530691A · Brown · 1985 [cited by applicant]
US 4534863A · Bacon et al. · 1985 [cited by applicant]
US 4643714A · Brose · 1987 [cited by applicant]
US 4647279A · Mulzet et al. · 1987 [cited by applicant]
US 4655742A · Vantard · 1987 [cited by applicant]
US 4680025A · Kruger et al. · 1987 [cited by applicant]
US 4684361A · Feldman et al. · 1987 [cited by applicant]
US 4692136A · Feldman et al. · 1987 [cited by applicant]
US 4708712A · Mulzet · 1987 [cited by applicant]
US 4713176A · Schoendorfer et al. · 1987 [cited by applicant]
US 4734089A · Cullis · 1988 [cited by applicant]
US 4740202A · Stacey et al. · 1988 [cited by applicant]
US 4740313A · Schoendorfer et al. · 1988 [cited by applicant]
US 4755300A · Fischel et al. · 1988 [cited by applicant]
US 4767396A · Powers · 1988 [cited by applicant]
US 4795419A · Yawn et al. · 1989 [cited by applicant]
US 4795448A · Stacey et al. · 1989 [cited by applicant]
US 4806247A · Schoendorfer et al. · 1989 [cited by applicant]
US 4806252A · Brown et al. · 1989 [cited by applicant]
US 4808307A · Fischel et al. · 1989 [cited by applicant]
US 4850995A · Tie et al. · 1989 [cited by applicant]
US 4869812A · Schoendorfer et al. · 1989 [cited by applicant]
US 4871462A · Fischel et al. · 1989 [cited by applicant]
US 4876013A · Shmidt et al. · 1989 [cited by applicant]
US 4889524A · Fell et al. · 1989 [cited by applicant]
US 4898675A · Lavender · 1990 [cited by applicant]
US 4911833A · Schoendorfer et al. · 1990 [cited by applicant]
US 4934995A · Cullis · 1990 [cited by applicant]
US 4940543A · Brown et al. · 1990 [cited by applicant]
US 4943273A · Pages · 1990 [cited by applicant]
US 4968295A · Neumann · 1990 [cited by applicant]
US 4980054A · Lavender · 1990 [cited by applicant]
US 4983156A · Knelson · 1991 [cited by applicant]
US 4983158A · Headley · 1991 [cited by applicant]
US 4985153A · Kuroda et al. · 1991 [cited by applicant]
US 4994188A · Prince · 1991 [cited by applicant]
US 5039401A · Columbus et al. · 1991 [cited by applicant]
US 5045048A · Kaleskas et al. · 1991 [cited by applicant]
US 5098372A · Jonsson · 1992 [cited by applicant]
US 5098373A · Polaschegg · 1992 [cited by applicant]
US 5100372A · Headley · 1992 [cited by applicant]
US 5100564A · Pall et al. · 1992 [cited by applicant]
US 5112298A · Prince et al. · 1992 [cited by applicant]
US 5114396A · Unger et al. · 1992 [cited by applicant]
US 5135667A · Schoendorfer · 1992 [cited by applicant]
US 5141486A · Antwiler et al. · 1992 [cited by applicant]
US 5147290A · Jonsson · 1992 [cited by applicant]
US 5154716A · Bauman et al. · 1992 [cited by applicant]
US 5174894A · Ohsawa et al. · 1992 [cited by applicant]
US 5178603A · Prince · 1993 [cited by applicant]
US 5194145A · Schoendorfer · 1993 [cited by applicant]
US 5217426A · Bacehowski et al. · 1993 [cited by applicant]
US 5217427A · Cullis · 1993 [cited by applicant]
US 5234403A · Yoda et al. · 1993 [cited by applicant]
US 5254248A · Nakamura · 1993 [cited by applicant]
US 5273517A · Barone et al. · 1993 [cited by applicant]
US 5277701A · Christie et al. · 1994 [cited by applicant]
US 5298016A · Gordon · 1994 [cited by applicant]
US 5298171A · Biesel · 1994 [cited by applicant]
US 5300060A · Nelson · 1994 [cited by applicant]
US 5316540A · Mcmannis et al. · 1994 [cited by applicant]
US 5318511A · Riquier et al. · 1994 [cited by applicant]
US 5318512A · Neumann · 1994 [cited by applicant]
US 5348533A · Papillon et al. · 1994 [cited by applicant]
US 5368542A · Mcmannis et al. · 1994 [cited by applicant]
US 5368555A · Sussman et al. · 1994 [cited by applicant]
US 5386734A · Pusinelli · 1995 [cited by applicant]
US 5387174A · Rochat · 1995 [cited by applicant]
US 5387187A · Fell et al. · 1995 [cited by applicant]
US 5403272A · Deniega et al. · 1995 [cited by applicant]
US 5405308A · Headley et al. · 1995 [cited by applicant]
US 5417650A · Gordon · 1995 [cited by applicant]
US 5431814A · Jorgensen · 1995 [cited by applicant]
US 5437598A · Delbert · 1995 [cited by applicant]
US 5437624A · Langley · 1995 [cited by applicant]
US 5462667A · Wollinsky et al. · 1995 [cited by applicant]
US 5470483A · Bene et al. · 1995 [cited by applicant]
US 5484396A · Naficy · 1996 [cited by applicant]
US 5494592A · Latham et al. · 1996 [cited by applicant]
US 5496265A · Langley et al. · 1996 [cited by applicant]
US 5505685A · Delbert · 1996 [cited by applicant]
US 5514070A · Pages · 1996 [cited by applicant]
US 5543062A · Nishimura · 1996 [cited by applicant]
US 5551941A · Howell · 1996 [cited by applicant]
US 5585007A · Antanavich et al. · 1996 [cited by applicant]
US 5607579A · Latham et al. · 1997 [cited by applicant]
US 5649903A · Deniega et al. · 1997 [cited by applicant]
US 5651766A · Kingsley et al. · 1997 [cited by applicant]
US 5656163A · Brown · 1997 [cited by applicant]
US 5665061A · Antwiler · 1997 [cited by applicant]
US 5681273A · Brown · 1997 [cited by applicant]
US 5686696A · Baker, Jr. et al. · 1997 [cited by applicant]
US 5712798A · Langley et al. · 1998 [cited by applicant]
US 5728060A · Kingsley et al. · 1998 [cited by applicant]
US 5733253A · Headley et al. · 1998 [cited by applicant]
US 5733446A · Holm · 1998 [cited by applicant]
US 5733545A · Hood, III · 1998 [cited by applicant]
US 5738792A · Schoendorfer · 1998 [cited by applicant]
US 5762791A · Deniega et al. · 1998 [cited by applicant]
US 5779660A · Kingsley et al. · 1998 [cited by applicant]
US 5783085A · Fischel · 1998 [cited by applicant]
US 5792351A · Wehrle et al. · 1998 [cited by applicant]
US 5849203A · Brown et al. · 1998 [cited by applicant]
US 5882289A · Sakota et al. · 1999 [cited by applicant]
US 5906589A · Gordon et al. · 1999 [cited by applicant]
US 5919125A · Berch · 1999 [cited by applicant]
US 5964724A · Rivera et al. · 1999 [cited by applicant]
US 5970432A · Ishimoto et al. · 1999 [cited by applicant]
US 5980760A · Min et al. · 1999 [cited by applicant]
US 6007725A · Brown · 1999 [cited by applicant]
US 6059979A · Brown · 2000 [cited by applicant]
US 6080322A · Deniega et al. · 2000 [cited by applicant]
US 6183651B1 · Brown et al. · 2001 [cited by applicant]
US 6200287B1 · Keller et al. · 2001 [cited by applicant]
US 6204694B1 · Sunter et al. · 2001 [cited by applicant]
US 6207063B1 · Brown · 2001 [cited by applicant]
US 6234989B1 · Brierton et al. · 2001 [cited by applicant]
US 6251284B1 · Bischof et al. · 2001 [cited by applicant]
US 6284142B1 · Muller · 2001 [cited by applicant]
US 6287818B1 · Kazimir et al. · 2001 [cited by applicant]
US 6296602B1 · Headley · 2001 [cited by applicant]
US 6325775B1 · Thom et al. · 2001 [cited by applicant]
US 6348156B1 · Vishnoi et al. · 2002 [cited by applicant]
US 6405508B1 · Janesky · 2002 [cited by applicant]
US 6464624B2 · Pages · 2002 [cited by applicant]
US 6471855B1 · Odak · 2002 [cited by applicant]
US 6497676B1 · Childers et al. · 2002 [cited by applicant]
US 6558307B2 · Headley · 2003 [cited by applicant]
US 6623443B1 · Polaschegg · 2003 [cited by applicant]
US 6641552B1 · Kingsley et al. · 2003 [cited by applicant]
US 6695806B2 · Gelfand et al. · 2004 [cited by applicant]
US 6730054B2 · Pierce et al. · 2004 [cited by applicant]
US 6730055B2 · Bainbridge et al. · 2004 [cited by applicant]
US 6743192B1 · Sakota et al. · 2004 [cited by applicant]
US 6746547B2 · Cole et al. · 2004 [cited by applicant]
US 6983884B2 · Auchlinleck · 2006 [cited by applicant]
US 7050611B2 · Bodicker et al. · 2006 [cited by applicant]
US 7072769B2 · Fletcher-Haynes et al. · 2006 [cited by applicant]
US 7115205B2 · Robinson et al. · 2006 [cited by applicant]
US 7186231B2 · Takagi et al. · 2007 [cited by applicant]
US 7270645B2 · Langley et al. · 2007 [cited by applicant]
US 7282154B2 · Muller · 2007 [cited by applicant]
US 7354415B2 · Bainbridge et al. · 2008 [cited by applicant]
US 7476209B2 · Gara et al. · 2009 [cited by applicant]
US 7704454B1 · Langley et al. · 2010 [cited by applicant]
US 8204694B2 · Hauck et al. · 2012 [cited by applicant]
US 8287818B2 · Kantrowitz et al. · 2012 [cited by applicant]
US 8405508B2 · Burke · 2013 [cited by applicant]
US 8628489B2 · Pages et al. · 2014 [cited by applicant]
US 8702637B2 · Pages et al. · 2014 [cited by applicant]
US 8746547B2 · Mollstam et al. · 2014 [cited by applicant]
US 8759094B2 · Ranby et al. · 2014 [cited by applicant]
US 8840790B2 · Wegener et al. · 2014 [cited by applicant]
US 9011359B2 · Wegener et al. · 2015 [cited by applicant]
US 9095665B2 · Pagès et al. · 2015 [cited by applicant]
US 9283316B2 · Flexman · 2016 [cited by applicant]
US 9302042B2 · Pages et al. · 2016 [cited by applicant]
US 9364600B2 · Pagès et al. · 2016 [cited by applicant]
US 9393359B2 · Boggs et al. · 2016 [cited by applicant]
US 10758652B2 · Ragusa · 2020 [cited by applicant]
US 10946131B2 · Patel et al. · 2021 [cited by applicant]
US 10980934B2 · Ragusa · 2021 [cited by applicant]
US 11110216B2 · Patel et al. · 2021 [cited by applicant]
US 20010000018A1 · Truong et al. · 2001 [cited by applicant]
US 20010027156A1 · Egozy et al. · 2001 [cited by applicant]
US 20020043492A1 · Bischof · 2002 [cited by applicant]
US 20020062100A1 · Pierce et al. · 2002 [cited by applicant]
US 20020120227A1 · Childers et al. · 2002 [cited by applicant]
US 20020151804A1 · O'mahony et al. · 2002 [cited by applicant]
US 20030055375A1 · Holst et al. · 2003 [cited by applicant]
US 20030066807A1 · Suzuki · 2003 [cited by applicant]
US 20030125017A1 · Greene et al. · 2003 [cited by applicant]
US 20030125881A1 · Ryan · 2003 [cited by applicant]
US 20030140928A1 · Bui et al. · 2003 [cited by applicant]
US 20030175150A1 · Grimm · 2003 [cited by applicant]
US 20040183683A1 · Funahashi · 2004 [cited by applicant]
US 20040186409A1 · Cavalcanti et al. · 2004 [cited by applicant]
US 20040199098A1 · Pierce et al. · 2004 [cited by applicant]
US 20050131334A1 · Langley et al. · 2005 [cited by applicant]
US 20050209522A1 · Tadokoro et al. · 2005 [cited by applicant]
US 20050228238A1 · Monitzer · 2005 [cited by applicant]
US 20050235733A1 · Holst et al. · 2005 [cited by applicant]
US 20050258238A1 · Chapman · 2005 [cited by applicant]
US 20060058167A1 · Ragusa et al. · 2006 [cited by applicant]
US 20060093190A1 · Cheng et al. · 2006 [cited by applicant]
US 20060155236A1 · Gara et al. · 2006 [cited by applicant]
US 20060226086A1 · Robinson et al. · 2006 [cited by applicant]
US 20070018832A1 · Beigel et al. · 2007 [cited by applicant]
US 20070067452A1 · Fung et al. · 2007 [cited by applicant]
US 20070112289A1 · Cavalcanti et al. · 2007 [cited by applicant]
US 20070138069A1 · Roncadi et al. · 2007 [cited by applicant]
US 20070258626A1 · Reiner · 2007 [cited by applicant]
US 20070268130A1 · Yee et al. · 2007 [cited by applicant]
US 20080146993A1 · Krishna · 2008 [cited by applicant]
US 20090215602A1 · Min et al. · 2009 [cited by applicant]
US 20090275808A1 · Dimaio et al. · 2009 [cited by applicant]
US 20100100392A1 · Rothman et al. · 2010 [cited by applicant]
US 20120010062A1 · Fletcher et al. · 2012 [cited by applicant]
US 20120053501A1 · Brown et al. · 2012 [cited by applicant]
US 20120175313A1 · Barry, Jr. et al. · 2012 [cited by applicant]
US 20130081998A1 · Chamney et al. · 2013 [cited by applicant]
US 20130267884A1 · Boggs et al. · 2013 [cited by applicant]
US 20140039373A1 · Ragusa et al. · 2014 [cited by applicant]
US 20140356851A1 · Pagès et al. · 2014 [cited by applicant]
US 20150367063A1 · Kimura · 2015 [cited by applicant]
US 20180344910A1 · Ragusa · 2018 [cited by applicant]
US 20180344921A1 · Ragusa · 2018 [cited by applicant]
US 20190099541A1 · Ali et al. · 2019 [cited by applicant]
US 20200147289A1 · Patel et al. · 2020 [cited by applicant]
US 20200345924A1 · Ragusa · 2020 [cited by applicant]
US 20210015989A1 · Patel et al. · 2021 [cited by applicant]
US 20210043316A1 · Case et al. · 2021 [cited by applicant]
CN 2735985Y · 2005 [cited by applicant]
CN 102046223A · 2011 [cited by applicant]
CN 102395392A · 2012 [cited by applicant]
CN 104800905A · 2015 [cited by applicant]
CN 204446748U · 2015 [cited by applicant]
EP 0128683A2 · 1984 [cited by applicant]
EP 0171749A1 · 1986 [cited by applicant]
EP 0208061A1 · 1987 [cited by applicant]
EP 0229504A2 · 1987 [cited by applicant]
EP 0257755A1 · 1988 [cited by applicant]
EP 0350162A1 · 1990 [cited by applicant]
EP 0578086A1 · 1994 [cited by applicant]
EP 0619145A2 · 1994 [cited by applicant]
EP 0654277A1 · 1995 [cited by applicant]
EP 0664159A1 · 1995 [cited by applicant]
EP 0799645A1 · 1997 [cited by applicant]
EP 0885619A1 · 1998 [cited by applicant]
EP 1057534A1 · 2000 [cited by applicant]
EP 1295619A2 · 2003 [cited by applicant]
EP 1374927A1 · 2004 [cited by applicant]
EP 2650030A1 · 2013 [cited by applicant]
FR 2258898A1 · 1977 [cited by applicant]
JP S596952A · 1984 [cited by applicant]
JP S5969166A · 1984 [cited by applicant]
JP H0252665A · 1990 [cited by applicant]
JP H03131268A · 1991 [cited by applicant]
JP H0775746A · 1995 [cited by applicant]
JP H08131539A · 1996 [cited by applicant]
JP H09192215A · 1997 [cited by applicant]
JP 2002282352A · 2002 [cited by applicant]
JP 2002291872A · 2002 [cited by applicant]
JP 3936132B · 2007 [cited by applicant]
JP 2008506424A · 2008 [cited by applicant]
RU 2252788C1 · 2005 [cited by applicant]
SU 660718A1 · 1979 [cited by applicant]
SU 762982A1 · 1980 [cited by applicant]
SU 1146098A1 · 1985 [cited by applicant]
WO 8502561A1 · 1985 [cited by applicant]
WO 9000059A1 · 1990 [cited by applicant]
WO 9007383A1 · 1990 [cited by applicant]
WO 9406535A1 · 1994 [cited by applicant]
WO 9611747A2 · 1996 [cited by applicant]
WO 9633023A1 · 1996 [cited by applicant]
WO 0205059A2 · 2002 [cited by applicant]
WO 2007041716A1 · 2007 [cited by applicant]
WO 2017053055A1 · 2017 [cited by applicant]
WO 2018222441A1 · 2018 [cited by applicant]
WO 2019084278A1 · 2019 [cited by applicant]
Altunatas, F., et al., Comparison of Plateletpheresis on the Fenwal Amicus and Fresenius Com. Tec Cell Separators, Transfusion Medicine and Hemotherapy, vol. 35, pp. 368-373, 2008. [cited by applicant]
Amendment and Argument filed Dec. 15, 2021 in Japanese Application No. 2020202093 with English translation (12 pages). [cited by applicant]
Amendment and Argument filed on Aug. 6, 2021 in Korean Application No. 10-2020-7033247 with English translation (11 pages.). [cited by applicant]
Amendment and Reply in U.S. Appl. No. 16/739,441 dated Apr. 5, 2022, 13 pages. [cited by applicant]
Amendment filed in U.S. Appl. No. 17/306,099, dated Nov. 2, 2021, 17 pages. [cited by applicant]
Amendment in U.S. Appl. No. 17/306,099 dated Apr. 5, 2022, 18 pages. [cited by applicant]
Amendment to the application with English translation for Korean Patent Application No. 10-2020-7033175 dated May 24, 2021 (11 pages). [cited by applicant]
Anonymous, 21 CFR Parts 606, 610, 630, et l.; Requirements for Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use; Final Rule, Federal Register. vol. 80, 2015. [cited by applicant]
Anonymous, Code of Federal Regulations, §606.110 General donor eligibility requirements, Code of Federal Regulations, National Archives, May 2020. [cited by applicant]
Anonymous, Code of Federal Regulations, §630.10 General donor eligibility requirements, Code of Federal Regulations, National Archives, May 2020. [cited by applicant]
Anonymous, Code of Federal Regulations, §630.15 Donor eligibility requirements, Code of Federal Regulations, National Archives, May 2020. [cited by applicant]
Anonymous, Code of Federal Regulations, §640.65 Plasmapheresis, Code of Federal Regulations, National Archives, pp. 105-107, Apr. 2020. [cited by applicant]
Applicant-Initiated Interview Summary, U.S. Appl. No. 17/306,099, dated Nov. 5, 2021, 17 pages. [cited by applicant]
Argument in Response to Notice of Preliminary Rejection in Korean Application No. 10-2020-7031496 dated Nov. 10, 2022. [cited by applicant]
Bialkowski W., et al., Citrate anticoagulation: Are blood donors donating bone?, Journal of clinical apheresis, United States, vol. 31, pp. 459-463, Oct. 2016. [cited by applicant]
Bird et al., “New gender-specific formulae for estimating extracellular fluid vol. from height and weight in adults,” Nuclear Medicine Communications. vol. 42. No. 1. Oct. 9, 2020, (Oct. 9, 2020), 2 pages. [cited by applicant]
Blaha, M. et al., Experience with extracorporeal elimination therapy in myasthenia gravis, Transfusion and Apheresis Science Elsevier Science, London, GB, vol. 45, pp. 252-256, 2011. [cited by applicant]
Body fluid compartments of a 70-kg adult man, PhysiologyWeb [online], Nov. 2, 2015—4-5, 16-18 (Nov. 14, 2015), Retrieved from the Internet (2 pages). [cited by applicant]
Burgstaler, E. A., Blood component collection by apheresis, Journal of clinical apheresis, United States, Journal 01 clinical apheresis, United States, vol. 21, pp. 142-151, Jul. 2006. [cited by applicant]
Burgstaler, E.A., et al., Paired comparison of therapeutic plasma exchange using the Fenwal Amicus versus TerumoBCT Spectra Optia, Journal of clinical apheresis, United States, vol. 33, pp. 265-273, Jun. 2018. [cited by applicant]
Canadian Office Action for Canadian Application No. 3099428, dated Nov. 14, 2022, 5 pages. [cited by applicant]
Canadian Requisition in Accordance with Subsection 86(2) of the Patent Rules dated Sep. 28, 2021 for Canadian Application No. 3,899,420. [cited by applicant]
Caridian BCT; Operator's Manual: Trima Accel® Automated Blood Collection System for Version 6.0 with Automated RBC Processes; Part No. 777095-197, Jun. 2010, (296 pages). [cited by applicant]
Charifa, A. et al., Transfusion medicine equations made internet accessible, American Journal of Clinical Pathology 20181001, Oxford University Press, vol. 150, Oct. 2018. [cited by applicant]
China National Intellectual Property Administration Notification of the First Office Action dated Dec. 6, 2021 for Chinese International Application No. 201980031598.1. [cited by applicant]
Colpo, A., et al., Therapeutic apheresis during pregnancy: A single center experience, Transfusion And Apheresis Science, Elsevier Science, London, GB, Sep. 5, 2019. [cited by applicant]
Communication pursuant to Article 94(3) EPC, Application No. 21198088.3, dated Jun. 13, 2022, 6 pages. [cited by applicant]
Compliance Program Guidance Manual, Chapter 42—Blood and Blood Components, Inspection of Source Plasma Establishments, Brokers, Testing Laboratories, and Contractors—7342.002, Completion Date: Jan. 31, 2019, (63 pages). [cited by applicant]
Cordts, P.R. et al., Poor predictive value of hematocrit and hemodynamic parameters for erythrocyte deficits after extensive elective vascular operations, Surgery, gynecology & obstetrics, United States, vol. 175, pp. 2… [cited by applicant]
De Back, D. Z. et al., Therapeutic plasma apheresis: Expertise and indications, Transfusion and Apheresis Science, vol. 58, pp. 254-257, Jun. 2019. [cited by applicant]
Director, Center for Biologics Evaluation and Research, Volume Limits for Automated Collection of Source Plasma, Nov. 4, 1992 (3 pages). [cited by applicant]
Evers, J. et al., Distribution of citrate and citrate infusion rate during donor plasmaphereses, Journal of clinical apheresis, United States, vol. 31, pp. 59-62, Feb. 2016. [cited by applicant]
Examination Report in AU 2021204735 (dated Aug. 18, 2022). [cited by applicant]
Examination report No. 1 for standard patent application for Australian patent No. 2019274489 dated Nov. 16, 2020 (4 pages). [cited by applicant]
Examination report No. 1 for standard patent application for Australian patent No. 2020267188 dated Nov. 25, 2020 (7 pages). [cited by applicant]
Examiner Requisition in Canada App. 3,099,428 dated Mar. 28, 2022, 4 pages. [cited by applicant]
Extended EP Search Report in EP Application No. 21198088 (dated Nov. 10, 2021). [cited by applicant]
Extended European Search Report dated Nov. 8, 2021 for European Application No. 21183088.0. [cited by applicant]
Extended European Search Report, counterpart EP Application No. 21168049.1 (Aug. 17, 2021) (8 pages). [cited by applicant]
Extended European Search Report, counterpart EP Application No. 21168049.1 (dated Aug. 17, 2021) (8 pages). [cited by applicant]
Feldschuh, J. et al., Prediction of the Normal Blood Volume Relation of Blood Volume To Body Habitus, Circulation 1977, vol. 56, pp. 605-612, Oct. 1977. [cited by applicant]
Feldschuh, J. et al., The importance of correct norms in blood volume measurement, The American journal of the medical sciences, United States, vol. 334, pp. 41-46, Jul. 2007. [cited by applicant]
Fenwal: AmicusTM Separator: Operator's Manual SW v. 4.3; Ref 4R4580, 4R4580R, Jun. 2011, (501 pages). [cited by applicant]
Fenwal: AmicusTM Separator: Therapeutics Supplement Manual SW v. 4.2, Mononuclear Cell Collection + Therapeutic Plasma Exchange; Ref 4R4580, 4R4580R, Apr. 2011, (372 pages). [cited by applicant]
Fenwal: AmicusTM Separator: Therapeutics Supplement Manual SW v. 4.3, Mononuclear Cell Collection + Therapeutic Plasma Exchange; Ref 4R4580, 4R4580R, Mar. 2012, 372 pages. [cited by applicant]
First Examination Report in Saudi Arabia patent application 520420610 based on PCT/WO/US2019/033318 (11 pages) and partial translation thereof (2 pages). [cited by applicant]
Fresenius Kabi: Amicus Separator: Operator's Manual SW v. 5.1, vol. 2—Platelets with Concurrent Plasma or RBC Collection, Ref 4R4580, 4R4580R, 4R4580TH, 6R4580, GR4580R, Mar. 2017, 352 pages. [cited by applicant]
Gokay, S. et al., Long-term efficacy of lipoprotein apheresis in the management of familial hypercholesterolaemia: 37 Application of two different apheresis techniques in childhood, Transfusion And Apheresis Science, El… [cited by applicant]
Hadem, J. et al., Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective 33 observational single-centre study of 23 patients, BMC Anesthesiology, Biomed Central, London, GB, vol. … [cited by applicant]
Hafer, C. et al., Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective 38 crossover study, International urology and Nephrology, Akademiai, Budapest, HU, vol. 48, pp. 133-138, 2016. [cited by applicant]
Hafer, C. et al., Pro: High dose of therapeutic plasma exchange-mind the gap!, Nephrology, dialysis, transplantation: 40 official publication of the European Dialysis and Transplant Association—European Renal Associatio… [cited by applicant]
Hattersley, J.G. et al., Describing the effectiveness of immunosuppression drugs and apheresis in the treatment of 30 transplant patients, Computer Methods And Programs In Biomedicine, Amsterdam, NL, vol. 109, pp. 126-1… [cited by applicant]
Hauser, R. G. et al., Transfusion Medicine Equations Made Internet Accessible, Transfusion Medicine Reviews, vol. 34, 2020. [cited by applicant]
International Search Report (17 pages) and Notification (2 pages) in International app No. PCT/US22/27484 dated May 3, 2022. [cited by applicant]
International Search Report and Written Opinion dated Dec. 1, 2021 for International Application No. PCT/US2021/047124. [cited by applicant]
International Search Report and Written Opinion dated Sep. 30, 2021 for International Application No. PCT/JS21/33835. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2018/033826, dated Aug. 3, 2018, 10 pages. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2018/57528, dated Jan. 7, 2019, 17 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US22/27484 dated May 3, 2022, 15 pages. [cited by applicant]
International Search Report and Written Opinion, counterpart International App. No. PCT/US2021/033835 (dated Sep. 30, 2021) (20 pages). [cited by applicant]
International Search Report and Written Opinion, counterpart International Appl. No. PCT/US2019/033318 (dated Aug. 21, 2019) (14 pages). [cited by applicant]
International Search Report and Written Opinion, counterpart International Application No. PCT/US2019/033318 dated Aug. 21, 2019, 14 pages. [cited by applicant]
Jia, Z.S. et al., Total blood volume of Asian patients undergoing cardiac surgery is far from that predicted by conventional methods, The Journal of cardiovascular surgery, Italy, vol. 54, pp. 423-430, Jun. 2013. [cited by applicant]
Kawai, Y. et al., Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support, Pediatric critical c… [cited by applicant]
Keklik, M. et al., Effectiveness of the haemonetics MCS cell separator in the collection of apheresis platelets, Transfusion and Apheresis Science Elsevier Science, London, GB, vol. 53, pp. 396-398, Aug. 2015. [cited by applicant]
Kochinke, F. et al., Modelling of LDL-apheresis: System efficacy and rebound kinetics, Plasma Therapy and Transfusion Technology, vol. 9, pp. 35-44, 1988. [cited by applicant]
Kuan, Jew-Win et al., A randomized double blind control trial comparing filgrastim and pegfilgrastim in cyclophosphamide peripheral blood hematopoietic stem cell mobilization, Transfusion and Apheresis Science Elsevier … [cited by applicant]
Kubeček, O. et al., Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resis… [cited by applicant]
Lambert, C. et al., Plasma extraction rate and collection efficiency during therapeutic plasma exchange with Spectra Optia in comparison with Haemonetics MCS+, Journal of clinical apheresis, United States, vol. 26, pp. … [cited by applicant]
Lemmens, H. et al., Estimating Blood Volume in Obese and Morbidly Obese Patients, Obesity Surgery, vol. 16, pp. 773-776, 2006. [cited by applicant]
Lin, Shi-Woei et al., Optimal collecting policy for apheresis platelets in a regional blood center, Vox Sanguinis, vol. 115, pp. 148-158, 2020. [cited by applicant]
Linderkamp, O. et al., Estimation and Prediction of Blood Volume in Infants and Children, European Journal of Pediatrics, vol. 125, pp. 227-234, Aug. 1977. [cited by applicant]
Lopez, A.J., et al., Monitoring and isolation of blood dendritic cells from apheresis products in healthy individuals: a platform for cancer immunotherapy, Journal of Immunological Methods, Sep. 15, 2002 Elsevier Scienc… [cited by applicant]
Maikowski & Ninnemann letter in European application 21168049.1, dated Mar. 29, 2022. [cited by applicant]
Maitta, Robert W., Current state of apheresis technology and its applications, Transfusion and Apheresis Science, vol. 57, pp. 606-613, Oct. 2018. [cited by applicant]
Merolle, L., et al., The effect of donor's characteristics on plasmapheresis products: insights for a personalized approach, Blood transfusion=Trasfusione del sangue, Italy, May 2020. [cited by applicant]
Miladi, M.I. et al., Relevance of palsma exchange in the treatment of Myasthenia gravis: Study of 11 cases, Revue de Medecine Interne, vol. 29, pp. 87-93, 2008. [cited by applicant]
Neff, L.P., The use of therapeutic plasma exchange (TPE) in the setting of refractory burn shock, Burns 2010 Elsevier Ltd., vol. 36, pp. 372-378, 2010. [cited by applicant]
Neyrinck, M.M. et al., Calculations in apheresis, Journal of clinical apheresis, vol. 30, pp. 38-42, Feb. 2015. [cited by applicant]
Notice for Reasons for Refusal in Japan App. 2020-202093 dated Jan. 11, 2022, 3 pages. [cited by applicant]
Notice of Allowance in U.S. Appl. No. 17/386,992 dated Feb. 9, 2022, 8 pages. [cited by applicant]
Notice of Preliminary Rejection with English translation for Korean Patent Application No. 10-2020-7033247 dated Mar. 22, 2021 (31 pages). [cited by applicant]
Notice of Preliminary Rejection with English translation for Korean Patent No. 10-2020-7033175 dated Mar. 22, 2021 (13 pages). [cited by applicant]
Notice of Reasons for Refusal in Japan Application 2020-202093 dated Jan. 11, 2022, 3 pages. [cited by applicant]
Notice of Reasons of Refusal with English translation, counterpart Japanese application 2020-202093 dated Jun. 15, 2021 (8 pages). [cited by applicant]
Notice of Reasons of Refusal with English translation, counterpart Japanese application 2020-202093 dated Jun. 15, 2021. [cited by applicant]
Notice of Reasons of Refusal with English translation, counterpart Japanese application 2020-557304 dated May 11, 2021 (8 pages). [cited by applicant]
Notice of Refusal in Japanese Patent Application No. 2022-104191 dated May 26, 2023. [cited by applicant]
Office Action in Canadian Patent Application 3,099,428 (dated Mar. 28, 2022). [cited by applicant]
Office Action in Russia Application 2021120042 (dated Feb. 28, 2022). [cited by applicant]
Office communication in U.S. Appl. No. 17/078,824 dated Nov. 3, 2021, 22 pages. [cited by applicant]
Office communication in U.S. Appl. No. 17/306,099 dated Dec. 6, 2021, 17 pages. [cited by applicant]
Office communication in U.S. Appl. No. 17/306,099 dated Sep. 23, 2021, 19 pages. [cited by applicant]
Partial Translation of Second Examination Report in Saudi Arabia Application 520420610, dated Jun. 11, 2023. [cited by applicant]
PCT/US21/33835, filed May 24, 2021. [cited by applicant]
PCT/US21/47124, filed Aug. 23, 2021. [cited by applicant]
PCT/US22/27484, filed May 31, 2022. [cited by applicant]